Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-06-17

Clinical Trial Update: Effects of Dapagliflozin in Non-diabetic Patients With Proteinuria [Phase 2]

View source ↗

Summary

Phase 2 results update on dapagliflozin in non-diabetic patients with proteinuria; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dapagliflozin (Farxiga) (dapagliflozin)

Snippet

Sponsor: Hiddo Lambers Heerspink | Conditions: Chronic Kidney Diseases, Proteinuria | Phase 2 | Status: COMPLETED | Results posted: 2024-06-17